Literature DB >> 7212061

Relationship between endogenous 3-methylhistidine excretion and body composition.

H C Lukaski, J Mendez, E R Buskirk, S H Cohn.   

Abstract

Fourteen healthy men (aged 20-30 yr) consumed two isocaloric, isonitrogenous diets in the sequence of a 4-day meat diet (MD) followed by a 7-day meal-free diet (MFD). Urinary 3-methylhistidine (3MH) excretion during the MD (513 +/- 21 mumol . day-1, mean +/- SE) was significantly higher (P less than 0.01) than day 3 of the MFD (230 +/- 10 mumol . day-1), after which the mean daily 3MH output was constant with a mean coefficient of variation of 4.5%. There was no change in fat-free body mass (FFBM) determined by densitometry at the start (62.3 +/- 1.8 kg) and the end (62.2 +/- 1.9 kg) of the 11-day dietary period. Mean muscle mass (MM) calculated from measurements of total-body potassium and nitrogen was 23.4 +/- 1.3 kg. Endogenous 3MH excretion was related more closely to MM (r = 0.91, P less than 0.001) than to FFBM measured by densitometry (r = 0.81, P less than 0.001). Only a low correlation coefficient (r = 0.33, P less than 0.05) was observed between 3MH and the nonmuscle component of FFBM. Urinary creatinine output also was correlated significantly with 3MH (r = 0.87; P less than 0.001) and MM (r = 0.79; P less than 0.01). It is concluded that because endogenous 3MH is significantly related to MM in man, it can be used as a marker to study in vivo total-body muscle protein degradation provided that the necessary dietary restrictions are observed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7212061     DOI: 10.1152/ajpendo.1981.240.3.E302

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Protein supplementation before and after resistance training in older men.

Authors:  Darren G Candow; Philip D Chilibeck; Marina Facci; Saman Abeysekara; Gordon A Zello
Journal:  Eur J Appl Physiol       Date:  2006-06-10       Impact factor: 3.078

Review 2.  Protein intake and athletic performance.

Authors:  P W Lemon; D N Proctor
Journal:  Sports Med       Date:  1991-11       Impact factor: 11.136

Review 3.  Techniques for the diagnosis of sarcopenia.

Authors:  Gaia Rubbieri; Enrico Mossello; Mauro Di Bari
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

Review 4.  Realising the Potential of Urine and Saliva as Diagnostic Tools in Sport and Exercise Medicine.

Authors:  Angus Lindsay; Joseph T Costello
Journal:  Sports Med       Date:  2017-01       Impact factor: 11.136

Review 5.  Techniques of measurement of body composition. Part II.

Authors:  D A Brodie
Journal:  Sports Med       Date:  1988-02       Impact factor: 11.136

6.  Independent and combined effects of liquid carbohydrate/essential amino acid ingestion on hormonal and muscular adaptations following resistance training in untrained men.

Authors:  Stephen P Bird; Kyle M Tarpenning; Frank E Marino
Journal:  Eur J Appl Physiol       Date:  2006-03-24       Impact factor: 3.078

7.  Endogenous 3-methylhistidine excretion in healthy women and men with reference to muscle protein metabolism.

Authors:  M Neuhäuser; K H Bässler
Journal:  Z Ernahrungswiss       Date:  1984-09

8.  Influence of age and resistance exercise on human skeletal muscle proteolysis: a microdialysis approach.

Authors:  Todd Trappe; Rick Williams; John Carrithers; Ulrika Raue; Birgitte Esmarck; Michael Kjaer; Robert Hickner
Journal:  J Physiol       Date:  2003-11-07       Impact factor: 5.182

9.  Assessing skeletal muscle mass: historical overview and state of the art.

Authors:  Steven B Heymsfield; Michael Adamek; M Cristina Gonzalez; Guang Jia; Diana M Thomas
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-02-15       Impact factor: 12.910

10.  Metabolomic profiling reveals severe skeletal muscle group-specific perturbations of metabolism in aged FBN rats.

Authors:  Sean M Garvey; Janis E Dugle; Adam D Kennedy; Jonathan E McDunn; William Kline; Lining Guo; Denis C Guttridge; Suzette L Pereira; Neile K Edens
Journal:  Biogerontology       Date:  2014-03-21       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.